$5.22
1.32%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$5.22
-9.11 63.57% 1M
-47.70 90.14% 6M
-41.40 88.80% YTD
-67.02 92.77% 1Y
-96,764.88 99.99% 3Y
-1,622,874.78 100.00% 5Y
-97,055,279,994.78 100.00% 10Y
-444,379,823,994.78 100.00% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
-0.07 1.32%

Key metrics

Basic
Market capitalization
$4.7m
Enterprise Value
$2.2m
Net debt
positive
Cash
$2.6m
Shares outstanding
100.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.5
EV/Sales
0.2 | 0.2
EV/FCF
negative
P/B
1.3
Financial Health
Equity Ratio
66.2%
Return on Equity
-162.7%
ROCE
-197.2%
ROIC
-319.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$8.8m | $9.3m
EBITDA
$-8.1m | -
EBIT
$-8.4m | $-8.6m
Net Income
$-9.9m | $-200.0k
Free Cash Flow
$-9.3m
Growth (TTM | estimate)
Revenue
-1.2% | 6.5%
EBITDA
50.0% | -
EBIT
49.2% | 21.7%
Net Income
50.6% | 98.1%
Free Cash Flow
37.5%
Margin (TTM | estimate)
Gross
63.2%
EBITDA
-92.1% | -
EBIT
-95.6%
Net
-112.1% | -2.1%
Free Cash Flow
-105.8%
More
EPS
$-94.6
FCF per Share
$-93.0
Short interest
0.9%
Employees
38
Rev per Employee
$230.0k
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nuwellis Inc forecast:

Buy
86%
Hold
14%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8.79 8.79
1% 1%
100%
- Direct Costs 3.24 3.24
15% 15%
37%
5.55 5.55
9% 9%
63%
- Selling and Administrative Expenses 12 12
24% 24%
141%
- Research and Development Expense 2.43 2.43
54% 54%
28%
-8.09 -8.09
50% 50%
-92%
- Depreciation and Amortization 0.31 0.31
11% 11%
4%
EBIT (Operating Income) EBIT -8.40 -8.40
49% 49%
-96%
Net Profit -9.85 -9.85
51% 51%
-112%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
GlobeNewsWire
4 days ago
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen Extended Length Catheter (dELC).
Neutral
GlobeNewsWire
6 days ago
Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid removal
Neutral
GlobeNewsWire
10 days ago
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date/Time: Thursday, Augus...
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO John Erb
Employees 38
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today